Angiocrine Bioscience, Inc.
Angiocrine Bioscience, Inc., is developing both research and therapeutic products using stem and endothelial cell related technologies.
TaggPic, Inc.
TaggPic transforms static 2D photos into auto-tagged, geo-positioned, and intelligently connected platforms. TaggPic’s crowd-fueled computer vision technology instantly recognizes landmarks, buildings, and other objects in images without the need for GPS data or manual tagging. TaggPic was acquired by Google in 2014.
WOTN, LLC
WOTN is a risk software company that provides an independent, real-time, simulation-based risk management platform for the $1T commercial mortgage backed securities market. The patent pending technology provides risk measurements on demand for loans and bonds in the derivative structure compliant with Basel in a comprehensive portfolio management system.
TeraPore Technologies, Inc.
TeraPore Technologies, Inc. develops membrane technologies for high-permeability, high-resolution separations including purification of biological fluids.
Immunovent, LLC
Immunovent, LLC is focused on the commercialization of next-generation technologies for allergy diagnosis. The company is developing the Local Allergy Mucosal Brush Test (LAMB-Dx), the first quantitative allergy diagnostic that will enable physicians to accurately test for both airborne and food allergies precisely where the clinical symptoms are occurring – in the mouth and nose.
ZYMtronix, Inc.
ZYMtronix is a biotechnology startup that services enzyme and pharmaceutical manufacturers. ZYMtronix immobilizes and optimizes biocatalysts for continuous manufacturing using green chemistry principles to lower the costs and increase the yields of drug manufacturing.
Lumidyne Technologies, LLC
Lumidyne develops next-generation fluorescent probes exhibiting superior brightness and stability compared with current commercially available reagents.
Bionic Sight, LLC
Bionic Sight develops neuro-prosthetics—prosthetic devices to treat blindness due to retinal degenerative disease that interact with the nervous system in order to restore function to damaged or degenerated tissue in the eye. The company is developing a technique involving gene therapy and a wearable device that correctly transmits light pulses to the brain, giving the wearer sight.
MedimageMetric, LLC
MedimageMetric, LLC, is developing and commercializing software for measuring organs and tissues from medical images for the Chinese market.
GenVec, Inc.
GenVec, Inc., is a biopharmaceutical company developing therapeutic drugs for cancer and vaccines for infectious diseases including HIV, malaria, foot-and-mouth disease, respiratory syncytial virus (RSV), HSV-2, and influenza. GenVec was acquired by Intrexon on June 16, 2017.
